We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu
Trial record 2 of 3 for:    carrimycin

Study to Evaluate Safety and Efficacy of Carrimycin for Treatment of Severe Coronavirus Disease 2019 (COVID-19) in Hospitalized Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04672564
Recruitment Status : Suspended (sponsor strategy change)
First Posted : December 17, 2020
Last Update Posted : August 8, 2022
Information provided by (Responsible Party):
Shenyang Tonglian Group CO., Ltd

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : November 25, 2022
Estimated Study Completion Date : November 25, 2022